Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qiju Granules
- Development stage
- Unknown
- Lead developer
- Beijing Yingkerei Pharmaceutical Technology
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Qiju Granules (杞菊颗粒) is a Traditional Chinese Medicine (TCM) botanical drug candidate developed by Beijing Yingkerui Innovative Drug Research Co., Ltd. It is formulated as granules for oral administration and is currently in Phase II clinical development for the treatment of intermediate age-related macular degeneration (AMD). The drug is specifically indicated for patients diagnosed with the "liver and kidney yin deficiency" syndrome according to TCM principles. The formulation typically centers on extracts of *Lycium barbarum* (Goji berry) and *Chrysanthemum morifolium* (Chrysanthemum), which are traditionally recognized for their ability to nourish the liver and kidneys and improve visual acuity.
- Other names
- 杞菊颗粒
Beyond the preview
Go deeper on Qiju Granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Qiju Granules.